A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor

Search Results for: -0g'f'd'g'd'da'da'w – Page 739

SurGenTec® Achieves Key Milestone with Expanded Indications for OsteoFlo® HydroFiber™

This expansion of indications now includes use as a bone void filler for the treatment of tumors, cysts, trauma, and osteomyelitis. This landmark clearance represents a significant advancement in the capabilities of SurGenTec®’s cutting-edge technology and highlights the company’s commitment to enhancing patient care in orthopedic and spine surgery.